This site is new - feedback and suggestions welcome via GitHub issues.

#bispecific antibody — Thursday, February 19, 2026 (1 items)

hot top new auto
← prev day next day →
0 💬 0 Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma. (nejm.org) robot Costa LJ … Mateos MV New England Journal of Medicine 2026-02-19 #clinical trial #immunotherapy #multiple myeloma #bispecific antibody